PARP inhibitors have been approved for the treatment of several cancers, including ovarian, breast, pancreatic and prostate cancers with BRCA mutations or other homologous recombination repair ...

A phase 1b/2 trial in triple-negative breast cancer will assess LP-184 alone and with a PARP inhibitor in advanced cases.

Positive results of PARP inhibitor and CAR T-cell treatments highlight advances in research for neuroblastoma.

It's a necessary investment. If you want to check out each property before ponying up the dough but can't quite find them, use the Schedule 1 property map above to find each one. Our list of the ...

Disclaimer: Schedule 1 is a fictional, satirical videogame, and the information in this guide relates only to the game. Where do you find all Schedule 1 dealers? To keep your new business running ...

blazed a trail for the new class of PARP drugs when it was approved in 2014 to treat ovarian cancer. The drug has gone on to become a huge success, generating sales of nearly $1.8 billion in ...

Ford Motor Company said on Monday that it expects to take a $1.5billion (£1.1bn) hit to operating profit from tariffs this year. The motoring giant followed in the tyre tracks of other automakers ...